Comparison of Compounded Topical Anesthetics

Description

The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

Conditions

Procedural Pain

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

Comparison of Compounded Topical Anesthetics for Pain Relief of Intense Pulsed Light, Pulse Dye Laser, and Microneedling Treatments

Comparison of Compounded Topical Anesthetics

Condition
Procedural Pain
Intervention / Treatment

-

Contacts and Locations

Lebanon

Dartmouth Hitchcock Dermatology Clinic, Lebanon, New Hampshire, United States, 03766

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men and women over 18, but not more than 75 years of age.
  • * Patients who have a regularly scheduled dermatology appointment for Intense Pulse Light (IPL), Pulse Dye Laser (PDL), or microneedling.
  • * Any subject who has a previous history of allergy, sensitivity, and contraindication to benzocaine, lidocaine, or tetracaine.
  • * Patients with cardiac/respiratory disease, seizure disorder, or neuropathies.
  • * Patients who are under treatment for a dermatologic condition that may interfere with the evaluation of the study.
  • * Pregnant women and women who are breastfeeding.
  • * Patients who report concurrent use of anxiolytics or opiates, which may interfere with the interpretation of results.

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Dartmouth-Hitchcock Medical Center,

Brian J Simmons, MD, PRINCIPAL_INVESTIGATOR, Dartmouth Health

Study Record Dates

2026-09